Tianlei Ying

8.5k total citations · 2 hit papers
140 papers, 4.9k citations indexed

About

Tianlei Ying is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Tianlei Ying has authored 140 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Molecular Biology, 48 papers in Radiology, Nuclear Medicine and Imaging and 45 papers in Infectious Diseases. Recurrent topics in Tianlei Ying's work include Monoclonal and Polyclonal Antibodies Research (48 papers), SARS-CoV-2 and COVID-19 Research (30 papers) and Glycosylation and Glycoproteins Research (17 papers). Tianlei Ying is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (48 papers), SARS-CoV-2 and COVID-19 Research (30 papers) and Glycosylation and Glycoproteins Research (17 papers). Tianlei Ying collaborates with scholars based in China, United States and New Zealand. Tianlei Ying's co-authors include Shibo Jiang, Yanling Wu, Lu Lu, Shuai Xia, Dimiter S. Dimitrov, Zheng‐Li Shi, Zhenlin Yang, Xiaolong Tian, Ailing Huang and Cheng Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Tianlei Ying

131 papers receiving 4.8k citations

Hit Papers

Potent binding of 2019 no... 2020 2026 2022 2024 2020 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody
    2020 838 citations Xiaolong Tian, Cheng Li et al. Emerging Microbes & Infections profile →
  2. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
    2020 518 citations Shuai Xia, Yanling Wu et al. Cellular and Molecular Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tianlei Ying China 35 2.6k 1.7k 955 762 481 140 4.9k
Meng Yuan United States 26 2.2k 0.9× 1.2k 0.7× 572 0.6× 411 0.5× 240 0.5× 72 3.4k
Shilong Fan China 18 3.4k 1.3× 2.5k 1.5× 373 0.4× 621 0.8× 250 0.5× 63 5.8k
Shuai Xia China 25 3.6k 1.4× 1.2k 0.7× 393 0.4× 520 0.7× 190 0.4× 61 4.6k
Xuanling Shi China 22 4.7k 1.8× 1.7k 1.0× 550 0.6× 609 0.8× 263 0.5× 50 6.0k
Ching‐Lin Hsieh United States 19 5.2k 2.0× 1.7k 1.1× 553 0.6× 706 0.9× 272 0.6× 30 6.7k
Olubukola M. Abiona United States 6 4.9k 1.9× 1.5k 0.9× 498 0.5× 516 0.7× 223 0.5× 8 6.0k
Jory A. Goldsmith United States 10 5.5k 2.1× 2.0k 1.2× 632 0.7× 595 0.8× 228 0.5× 14 6.9k
Yanling Wu China 20 2.0k 0.8× 775 0.5× 481 0.5× 378 0.5× 214 0.4× 64 2.9k

Countries citing papers authored by Tianlei Ying

Since Specialization
Citations

This map shows the geographic impact of Tianlei Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tianlei Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tianlei Ying more than expected).

Fields of papers citing papers by Tianlei Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tianlei Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tianlei Ying. The network helps show where Tianlei Ying may publish in the future.

Co-authorship network of co-authors of Tianlei Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Tianlei Ying. A scholar is included among the top collaborators of Tianlei Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tianlei Ying. Tianlei Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Quanxiao, Yu Kong, Ailing Huang, et al.. (2025). An IL-15-modified NKp30×HER2 trispecific NK cell engager enhances NK cell activation and tumor cell killing. Journal of Leukocyte Biology. 117(8).
2.
Wu, Tong, Peiran Zhao, Zheng Chen, et al.. (2025). Neuro‐Cancer Interactions Shape Glioma Intratumoral Heterogeneity. Advanced Science. 12(38). e06694–e06694.
3.
Zhao, Peiran, et al.. (2025). Piezo‐Bio Interaction Interfaces: The Linchpin of Piezoelectric Nanomaterials Toward Biomedicine. Advanced Materials. e07881–e07881.
4.
Zhu, Xiaoyi, Qingyuan Xu, Yanling Wu, et al.. (2025). Oral Administration of Trifluoroacetyl Chitosan–Encapsulated Redshifted Immunofluorophore for NIR‐II Bioimaging of Colorectal Metastases. Advanced Healthcare Materials. 15(5). e01877–e01877.
5.
Huang, Keke, Yuqing Wu, Yu Kong, et al.. (2025). Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation. Cellular and Molecular Immunology. 22(8). 918–934. 2 indexed citations
6.
Li, Cheng, Wenping Song, Yu Kong, et al.. (2025). Enhancing vaccine half-life as a novel strategy for improving immune response durability of subunit vaccines. PLoS Pathogens. 21(1). e1012845–e1012845.
7.
Cai, Huiyu, et al.. (2024). Pretrainable geometric graph neural network for antibody affinity maturation. Nature Communications. 15(1). 7785–7785. 12 indexed citations
8.
Ma, Xiaojie, et al.. (2024). Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate. PubMed. 7(2). 114–122. 12 indexed citations
9.
Chen, Junbo, Yibing Cheng, Yao-Qing Chen, et al.. (2023). Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection. PLoS Pathogens. 19(6). e1011420–e1011420. 5 indexed citations
10.
Baroutian, Saeid, et al.. (2023). Combination of marine bioactive compounds and extracts for the prevention and treatment of chronic diseases. Frontiers in Nutrition. 9. 25 indexed citations
11.
Huang, Shigao, Fuqiang Xing, Yeneng Dai, et al.. (2023). Navigating chimeric antigen receptor-engineered natural killer cells as drug carriers via three-dimensional mapping of the tumor microenvironment. Journal of Controlled Release. 362. 524–535. 9 indexed citations
12.
Dai, Changhao, Mingquan Guo, Yanling Wu, et al.. (2021). Ultraprecise Antigen 10-in-1 Pool Testing by Multiantibodies Transistor Assay. Journal of the American Chemical Society. 143(47). 19794–19801. 64 indexed citations
13.
Hua, Kang, Xuejun Wang, Mingquan Guo, et al.. (2021). Ultrasensitive Detection of SARS-CoV-2 Antibody by Graphene Field-Effect Transistors. Nano Letters. 21(19). 7897–7904. 96 indexed citations
14.
Yu, Fei, Rong Xiang, Xiaoqian Deng, et al.. (2020). Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2. Signal Transduction and Targeted Therapy. 5(1). 212–212. 77 indexed citations
15.
Tian, Xiaolong, Cheng Li, Ailing Huang, et al.. (2020). Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerging Microbes & Infections. 9(1). 382–385. 838 indexed citations breakdown →
16.
Aipire, Adila, Pengfei Yuan, Shanshan Cai, et al.. (2020). Preparation, Characterization, and Immuno-Enhancing Activity of Polysaccharides from Glycyrrhiza uralensis. Biomolecules. 10(1). 159–159. 33 indexed citations
17.
Ma, Ruoyu, Hui Zhang, Xuefeng Li, et al.. (2020). Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth. The Journal of Experimental Medicine. 217(11). 115 indexed citations
18.
Doremalen, Neeltje van, Darryl Falzarano, Tianlei Ying, et al.. (2017). Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. Antiviral Research. 143. 30–37. 47 indexed citations
19.
Agrawal, Anurodh Shankar, Tianlei Ying, Xinrong Tao, et al.. (2016). Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection. Scientific Reports. 6(1). 31629–31629. 43 indexed citations
20.
Chen, Weizao, Yang Feng, Ponraj Prabakaran, et al.. (2013). Exceptionally Potent and Broadly Cross-Reactive, Bispecific Multivalent HIV-1 Inhibitors Based on Single Human CD4 and Antibody Domains. Journal of Virology. 88(2). 1125–1139. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng Yuan Breakdown of academic impact, for papers by Shilong Fan Breakdown of academic impact, for papers by Shuai Xia Breakdown of academic impact, for papers by Xuanling Shi Breakdown of academic impact, for papers by Ching‐Lin Hsieh Breakdown of academic impact, for papers by Olubukola M. Abiona Breakdown of academic impact, for papers by Jory A. Goldsmith Breakdown of academic impact, for papers by Yanling Wu
Rankless by CCL
2026